Clinical trial

Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

NCT07345026

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-01-08

PhaseNA

Study timeline

Study start (estimated)2026-01-08Date precision: day

Registry last updated2026-01-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Mastectomy, Segmentalunresolved

Interventions

Acellular Dermal Matrix (SureDerm BCS)DEVICE

Standard Breast-Conserving SurgeryPROCEDURE

Sponsors & collaborators

Seoul St. Mary's Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07345026 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.